Format

Send to

Choose Destination
Ann Thorac Surg. 2016 Aug;102(2):e105-7. doi: 10.1016/j.athoracsur.2016.01.074.

Valvular Cytomegalovirus Endocarditis.

Author information

1
Midwestern University, Downers Grove, Illinois.
2
Department of Cardiovascular and Thoracic Surgery, John H. Stroger Jr. Hospital, Chicago, Illinois.
3
Department of Pathology, John H. Stroger Jr. Hospital, Chicago, Illinois.
4
Department of Thoracic and Cardiac Surgery, Rush University Medical Center, Chicago, Illinois. Electronic address: douglas_r_smego@rush.edu.

Abstract

Endocarditis is a rare presentation for cytomegalovirus (CMV) infection. We present the case of a 49-year-old man who underwent mitral and tricuspid valve replacement for valvular CMV endocarditis. The patient's past medical history was significant for human immunodeficiency virus, intravenous drug abuse, and chronic hepatitis B. During his clinical course, he was found to have tricuspid and mitral valve vegetations. After progressive valvular destruction despite antibiotic therapy, he underwent successful mitral and tricuspid valve replacement. Pathologic analysis of the culture-negative valve specimens were found to contain inclusion bodies consistent with CMV, and quantitative serum polymerase chain reaction returned a highly elevated CMV DNA count.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center